Nardella, Caterina
 Distribuzione geografica
Continente #
NA - Nord America 2.282
AS - Asia 843
EU - Europa 497
SA - Sud America 115
AF - Africa 15
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.757
Nazione #
US - Stati Uniti d'America 2.250
SG - Singapore 351
CN - Cina 204
RU - Federazione Russa 111
VN - Vietnam 98
BR - Brasile 97
IT - Italia 73
GB - Regno Unito 49
FR - Francia 44
KR - Corea 35
FI - Finlandia 34
SE - Svezia 32
HK - Hong Kong 30
IN - India 30
LV - Lettonia 28
DE - Germania 23
TR - Turchia 22
CA - Canada 19
BE - Belgio 18
IQ - Iraq 15
JP - Giappone 14
PL - Polonia 12
BG - Bulgaria 11
NL - Olanda 10
MX - Messico 9
ID - Indonesia 8
ZA - Sudafrica 8
AT - Austria 7
BD - Bangladesh 7
ES - Italia 7
CH - Svizzera 6
PK - Pakistan 6
UA - Ucraina 6
LT - Lituania 5
VE - Venezuela 5
AR - Argentina 4
CZ - Repubblica Ceca 4
SK - Slovacchia (Repubblica Slovacca) 4
HR - Croazia 3
IE - Irlanda 3
PE - Perù 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
CL - Cile 2
EG - Egitto 2
HU - Ungheria 2
JO - Giordania 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PR - Porto Rico 2
RO - Romania 2
TH - Thailandia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
BO - Bolivia 1
CO - Colombia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
GD - Grenada 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MA - Marocco 1
MK - Macedonia 1
MT - Malta 1
MV - Maldive 1
NO - Norvegia 1
PS - Palestinian Territory 1
PY - Paraguay 1
SA - Arabia Saudita 1
TN - Tunisia 1
TW - Taiwan 1
Totale 3.757
Città #
Chandler 289
Fairfield 250
Ashburn 245
Singapore 217
Woodbridge 114
Wilmington 102
Houston 97
Seattle 97
San Jose 80
Cambridge 76
Santa Clara 67
Beijing 58
Dallas 58
Moscow 50
Princeton 50
Columbus 46
San Mateo 43
The Dalles 41
Seoul 35
Ann Arbor 34
Ho Chi Minh City 34
Los Angeles 34
Riga 28
Hong Kong 26
Lauterbourg 26
Helsinki 22
Hanoi 21
Jacksonville 19
Trento 18
Brussels 17
Izmir 16
San Diego 16
São Paulo 16
Orem 15
Chicago 13
London 13
Tokyo 13
Council Bluffs 12
New York 12
Warsaw 11
Chennai 10
Denver 10
Hefei 10
Sofia 10
Redondo Beach 9
Toronto 9
Buffalo 8
Johannesburg 8
Kensington 8
Salt Lake City 8
Dearborn 7
Baghdad 6
Boston 6
Jakarta 6
Munich 6
Phoenix 6
Stockholm 6
Zurich 6
Atlanta 5
Da Nang 5
Falkenstein 5
Frankfurt am Main 5
Milan 5
Paris 5
St Louis 5
Vienna 5
Amsterdam 4
Ankara 4
Elk Grove Village 4
Mexico City 4
Montreal 4
Mumbai 4
Nanjing 4
Rio de Janeiro 4
Zhengzhou 4
Belo Horizonte 3
Biên Hòa 3
Bratislava 3
Caracas 3
Dublin 3
Edinburgh 3
Guangzhou 3
Lancaster 3
Lappeenranta 3
Milwaukee 3
New Delhi 3
Ninh Bình 3
Norwalk 3
Ottawa 3
Pittsburgh 3
Poplar 3
Reston 3
San Francisco 3
Washington 3
Zagreb 3
Amman 2
Baku 2
Bandar Seri Begawan 2
Boardman 2
Brescia 2
Totale 2.716
Nome #
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer 174
Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events 159
Of model pets and cancer models: an introduction to mouse models of cancer 158
Differential requirement of mTOR in postmitotic tissues and tumorigenesis 156
Editorial: Precision medicine in oncology 155
MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells 153
Differential expression of S6K2 dictates tissue-specific requirement for S6K1 in mediating aberrant mTORC1 signaling and tumorigenesis 148
Faithfull modeling of PTEN loss driven diseases in the mouse 147
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis 146
Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer 144
Subtle variations in Pten dose determine cancer susceptibility 142
ETS rearrangements and prostate cancer initiation 139
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate 133
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation 130
Mechanism of Activation of Human Heparanase Investigated by Protein Engineering 129
Pro-senescence therapy for cancer treatment 128
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer 126
Integrating extracellular vesicle and circulating cell-free DNA analysis on a single plasma aliquot improves the detection of HER2 positivity in breast cancer patients 125
Circulating RNAs in prostate cancer patients 125
Characterization of the hepatitis C virus NS2/3 processing reaction by using a purified precursor protein 124
Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion 122
Radiolabeled heparan sulfate immobilized on microplate as substrate for the detection of heparanase activity 122
Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence 121
The APL paradigm and the "co-clinical trial" project 119
Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition 112
Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis 109
International Society for Extracellular Vesicles Workshop. QuantitatEVs: multiscale analyses, from bulk to single extracellular vesicle 97
Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence 88
MYC-driven gliosis impairs neuron-glia communication in amyotrophic lateral sclerosis 77
Totale 3.808
Categoria #
all - tutte 17.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.258


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 0 0 0 0 0 0 39 3 7
2021/2022235 20 6 0 18 6 12 4 63 18 42 10 36
2022/2023537 38 65 2 79 55 91 0 63 89 6 37 12
2023/2024137 16 22 6 6 11 21 13 2 4 8 6 22
2024/2025722 0 0 50 133 75 91 14 36 91 137 48 47
2025/20261.222 105 31 145 232 181 113 172 32 135 76 0 0
Totale 3.808